Results 211 to 220 of about 269,130 (350)

Managing Acute Severe Ulcerative Colitis in 2025 and Beyond. [PDF]

open access: yesCurr Gastroenterol Rep
Goyal MK, Hassan SA, Berinstein JA.
europepmc   +1 more source

GST Theta null genotype is associated with an increased risk for ulcerative colitis: a case–control study and meta-analysis of GST Mu and GST Theta polymorphisms in inflammatory bowel disease [PDF]

open access: bronze, 2014
Mark M. T. J. Broekman   +7 more
openalex   +1 more source

Frequency and impact of repeat colonoscopy as a treat‐to‐target approach in pediatric inflammatory bowel disease

open access: yesJPGN Reports, EarlyView.
Abstract Objectives Endoscopic healing (EH) is a treatment target in inflammatory bowel disease (IBD). However, adherence to repeat colonoscopy (RC) for EH assessment in pediatrics remains variable. We aimed to evaluate the frequency and timing of RC after diagnosis and its impact on treatment decisions at a large pediatric IBD center.
Kari Noel VanEvery   +5 more
wiley   +1 more source

P1222 Gut microbiome differences regarding lifestyle and the history of COVID-19 infection in ulcerative colitis patients [PDF]

open access: bronze
Zane Straume   +9 more
openalex   +1 more source

Impact of timing on mucosal healing during restaging endoscopy in pediatric Crohn's disease: A retrospective cohort study

open access: yesJPGN Reports, EarlyView.
Abstract While endoscopic remission is an important target in pediatric Crohn's disease (CD), no consensus for restaging timing exists. This retrospective cohort study assessed the timing and impact of restaging endoscopy in children with new CD in remission, comparing earlier ( ≤ 9 months) versus later endoscopy.
Anna Janecek   +7 more
wiley   +1 more source

Pyroptosis in ulcerative colitis: biomarkers and therapeutic targets. [PDF]

open access: yesJ Biomed Sci
Cruz H   +5 more
europepmc   +1 more source

Central blood volume in cirrhosis [PDF]

open access: yes, 1993
Bendtsen, Flemming   +2 more
core   +1 more source

A RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF PSYLLIUM FIBER AND FECAL MICROBIOTA TRANSPLANTATION FOR MILD TO MODERATE ULCERATIVE COLITIS [PDF]

open access: bronze
Lasha Gogokhia   +9 more
openalex   +1 more source

Home - About - Disclaimer - Privacy